Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,090 | 50,211 | 101,571 | 37,197 | 21,457 |
| Marketable Securities | 49,154 | 97,389 | N/A | 36,001 | N/A |
| Receivables | 7,047 | N/A | N/A | N/A | 83 |
| Inventories | 1,964 | N/A | N/A | 316 | 105 |
| TOTAL | $115,619 | $148,634 | $102,243 | $74,472 | $22,041 |
| Non-Current Assets | |||||
| PPE Net | 2,046 | 977 | 948 | 805 | 741 |
| Investments And Advances | 1,893 | 48,555 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,447 | 4,222 | 368 | 273 | 274 |
| TOTAL | $6,386 | $53,754 | $1,316 | $1,078 | $1,015 |
| Total Assets | $122,005 | $202,388 | $103,559 | $75,550 | $23,056 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,023 | 11,186 | 8,540 | 4,435 | 1,880 |
| Accrued Expenses | 9,554 | 6,711 | 4,925 | 1,950 | 687 |
| Other current liabilities | 1,859 | 1,585 | N/A | N/A | 570 |
| TOTAL | $21,436 | $19,482 | $13,465 | $7,035 | $3,137 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 650 | N/A |
| Other Non-Current Liabilities | 4,214 | 2,604 | 0 | 0 | 3,612 |
| TOTAL | $4,214 | $2,604 | $N/A | $N/A | $3,612 |
| Total Liabilities | $25,650 | $22,086 | $13,465 | $7,035 | $6,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,273 | 21,155 | N/A | N/A | N/A |
| Common Shares | 60 | 57 | 44 | 37 | 6 |
| Retained earnings | -356,501 | -228,017 | -122,871 | -47,214 | -27,214 |
| Other shareholders' equity | 271 | 276 | 0 | 0 | 0 |
| TOTAL | $96,355 | $180,302 | $90,094 | $68,515 | $16,307 |
| Total Liabilities And Equity | $122,005 | $202,388 | $103,559 | $75,550 | $23,056 |